P019: Unfavorable prognostic value of the predominance of THRLBCL-like histopathological growth patterns in nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)

por Dorokhina, Elena, Moiseeva, T.N., Kovrigina, A.M., Shupletsova, Irirna, Al-Radi, L.S., Chabaeva, Yu. A., Mangasarova, Ya.K.
Publicado 2022

P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with...

por Dorokhina, Elena, Moiseeva, T.N., Kovrigina, A.M., Shupletsova, Irirna, Al-Radi, L.S., Chabaeva, Yu. A., Mangasarova, Ya.K.
Publicado 2022

P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma.

por Mangasarova, Ya.K., Moiseeva, T.N., Al-Radi, L.S., Margolin, O.V., Gorenkova, L.G., Nesterova, E.S., Bagova, M.O., Fastova, E.A., Abdurashidova, R.R., Sarakaeva, Z.T., Dorokhina, Elena, Kravchenko, S.K., Magomedova, A.U., Zvonkov, E.E.
Publicado 2022